FALASCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.982
EU - Europa 181
AS - Asia 166
SA - Sud America 9
Totale 2.338
Nazione #
US - Stati Uniti d'America 1.980
SG - Singapore 104
DE - Germania 33
IT - Italia 28
RU - Federazione Russa 28
CN - Cina 27
HK - Hong Kong 27
IE - Irlanda 26
UA - Ucraina 17
FR - Francia 13
BR - Brasile 8
CZ - Repubblica Ceca 8
FI - Finlandia 7
GB - Regno Unito 7
PL - Polonia 6
JP - Giappone 3
AT - Austria 2
BE - Belgio 2
CA - Canada 2
DK - Danimarca 2
KR - Corea 2
CL - Cile 1
IN - India 1
LK - Sri Lanka 1
NL - Olanda 1
SE - Svezia 1
TW - Taiwan 1
Totale 2.338
Città #
Wilmington 609
Houston 506
Woodbridge 365
Singapore 98
Fairfield 76
Chandler 61
Ashburn 41
Ann Arbor 35
Cambridge 27
Hong Kong 27
Seattle 25
Dublin 21
Santa Clara 21
Rome 18
Medford 17
Dearborn 13
Beijing 12
Jacksonville 11
Brno 8
Lawrence 8
New York 8
Munich 6
San Diego 6
Council Bluffs 5
Kraków 5
Kunming 5
Menlo Park 5
Moscow 5
Nuremberg 5
Engelhard 4
Helsinki 3
Palo Alto 3
Brussels 2
Creede 2
Hefei 2
La Veta 2
Osaka 2
Saint Petersburg 2
St. George 2
Toronto 2
Atlanta 1
Castanhal 1
Chengdu 1
Chiswick 1
Colombo 1
Hounslow 1
Ibirubá 1
Kaohsiung 1
Lappeenranta 1
Los Angeles 1
Manaus 1
Melegnano 1
Mirassol 1
Mountain View 1
Nanjing 1
North Hollywood 1
Novokuznetsk 1
Osasco 1
Pisa 1
Pune 1
Rio de Janeiro 1
Shanghai 1
Shijiazhuang 1
São Luís 1
Teixeira de Freitas 1
University Park 1
Warsaw 1
Washington 1
Totale 2.103
Nome #
Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. 399
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells 395
Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication 382
TG2 regulates the heat-shock response by the post-translational modification of HSF1. 322
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 310
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. 273
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 66
ZFP750 affects the cutaneous barrier through regulating lipid metabolism 55
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois 42
Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for covid-19 therapy 36
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 33
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma 32
Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis 24
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection 22
AMBRA1 and SQSTM1 expression pattern in prostate cancer 5
Totale 2.396
Categoria #
all - tutte 6.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020209 0 0 0 0 0 0 0 0 69 46 48 46
2020/2021379 49 45 43 40 37 43 41 50 11 7 11 2
2021/202286 8 6 0 3 1 10 8 10 3 5 11 21
2022/2023139 10 18 1 19 20 21 13 9 15 0 3 10
2023/202496 13 5 5 3 10 15 0 1 10 12 2 20
2024/2025282 6 100 49 17 15 26 41 24 4 0 0 0
Totale 2.396